Stockscreener 앱 받기
4.77
6.84%
-0.35
시간 외 거래:
4.77
전일 마감가:
$5.12
열려 있는:
$5.03
하루 거래량:
463.86K
Relative Volume:
0.66
시가총액:
$329.68M
수익:
-
순이익/손실:
$-89.66M
주가수익비율:
-1.9707
EPS:
-2.4205
순현금흐름:
$-81.90M
1주 성능:
-22.44%
1개월 성능:
-28.38%
6개월 성능:
+153.72%
1년 성능:
+136.14%
1일 변동 폭
$4.72
$5.075
1주일 범위
$4.72
$6.305
52주 변동 폭
$0.8801
$7.80
Pepgen Inc Stock (PEPG) Company Profile
명칭
Pepgen Inc
전화
703-456-8000
주소
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
4.77 | 353.87M | 0 | -89.66M | -81.90M | -2.4205 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-09 | 개시 | Guggenheim | Buy |
| 2024-12-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-07-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-21 | 개시 | H.C. Wainwright | Buy |
Pepgen Inc 주식(PEPG)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - PR Newswire
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PEPG SEC FilingsPepGen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
COMMODORE CAPITAL LP Acquires Additional Shares in PepGen Inc - GuruFocus
Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - FinancialContent
How much upside is left in PepGen (PEPG)? Wall Street analysts think 75.44% - MSN
Boxer Capital Management LLC Invests $1.16 Million in PepGen, Inc. $PEPG - MarketBeat
Commodore Capital LP Invests $10.89 Million in PepGen, Inc. $PEPG - MarketBeat
FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial - Sahm
PepGen shares slide 20% as FDA clinical hold overshadows earnings beat - MSN
Aug Volume: Is PepGen Inc stock a smart retirement pickPrice Action & Technical Pattern Recognition Alerts - baoquankhu1.vn
PepGen falls 20% despite earnings beat on FDA hold concerns By Investing.com - Investing.com Nigeria
Commodore Capital discloses 5.1% stake in PepGen (PEPG) - Stock Titan
PEPG Stock Price, Quote & Chart | PEPGEN INC (NASDAQ:PEPG) - ChartMill
PepGen CEO McArthur sells $32875 in shares By Investing.com - Investing.com Nigeria
FDA places partial clinical hold on PepGen’s DM1 trial - Investing.com Nigeria
PepGen unveils new research at MDA2026 poster session - Traders Union
Research Analysts Offer Predictions for PepGen Q1 Earnings - MarketBeat
Profit Review: Can PepGen Inc. stock double in the next year2026 Short Interest & Stepwise Trade Execution Plans - baoquankhu1.vn
Aug Momentum: What are the analyst revisions for NEOVIs PepGen Inc stock a good investment in YEARTrade Entry Summary & Short-Term Trading Alerts - baoquankhu1.vn
PepGen CEO McArthur sells $32875 in shares - Investing.com
Surprises Report: How does PepGen Inc correlate with NasdaqJuly 2025 PreEarnings & AI Driven Stock Reports - baoquankhu1.vn
PepGen (PEPG) CFO’s 2,084-share automatic sale covers RSU tax withholding - Stock Titan
PepGen (PEPG) CEO share sale covers RSU tax withholding obligations - Stock Titan
Grocery Outlet Posts Downbeat Q4 Earnings, Joins SES AI, PepGen And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Sahm
Stifel reiterates Buy on PepGen stock amid partial clinical hold By Investing.com - Investing.com Australia
PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - wjfw.com
PepGen Inc. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
FDA curtails Pepgen’s Freedom2 operate in DM1 - bioworld.com
PepGen Still On Track For PGN-EDODM1 Readouts Despite FDA Partial Hold - Citeline News & Insights
PepGen: Stock Slides On FDA Study HoldI'm Firmly On The Sidelines (NASDAQ:PEPG) - Seeking Alpha
PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA - BioPharma Dive
Stifel reiterates Buy on PepGen stock amid partial clinical hold - Investing.com Nigeria
PepGen: Clinical and Safety Uncertainties, FDA Partial Hold, and Valuation Gap Support Underperform Rating - TipRanks
PepGen stock slides on FDA partial hold (PEPG:NASDAQ) - Seeking Alpha
PepGen Updates EDO Platform and DM1 Program Outlook - TipRanks
PepGen falls 20% despite earnings beat on FDA hold concerns - Investing.com India
Why Is PepGen Stock Falling Thursday?PepGen (NASDAQ:PEPG) - Benzinga
FDA places partial clinical hold on PepGen’s DM1 trial By Investing.com - Investing.com Canada
US FDA puts partial clinical hold on PepGen’s muscle disease drug trial - 1470 & 100.3 WMBD
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights - PharmiWeb.com
PepGen Announces Regulatory Updates on FREEDOM2 - pharmiweb.com
Stocks to Watch : Broadcom, StubHub, PepGen, Veeva Systems - marketscreener.com
PepGen stock plunges 26% on FDA partial clinical hold - Investing.com South Africa
PepGen reports Q4 EPS (27c), consensus (39c) - TipRanks
PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1 - TipRanks
PepGen's Phase 2 Trial of Drug to Treat Multisystem Disorder Placed on Hold by US FDA - marketscreener.com
PepGen Inc reports results for the quarter ended December 31Earnings Summary - TradingView
US FDA puts partial clinical hold on PepGen's muscle disease drug trial - AOL.com
Pepgen Inc (PEPG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):